As a physician who has committed the past 15 years of my professional career to the medical treatment of overweight and obese patients, I feel the need to express my concern over Alli, the recently FDA approved OTC “fat blocker”, and with GlaxoSmithKline, the pharmaceutical company who owns it.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.